| Patents for C12R 1 - Micro-organisms (92,025) |
|---|
| 04/18/2000 | US6051419 Genes which influence pichia proteolytic activity, and uses therefor |
| 04/18/2000 | US6051416 Methods for producing enhanced antigenic Helicobacter sp. |
| 04/18/2000 | US6051408 Gene and gene structure coding for an aminotransferase, and microorganisms which express this gene |
| 04/18/2000 | US6051407 A dna encoding a protein; regulating the production of cellulose in prokaryotic and eukaryotic cells |
| 04/18/2000 | US6051406 Keratan sulfate 6-sulfotransferase and DNA coding for the same |
| 04/18/2000 | US6051401 Methods and constructs for protein expression |
| 04/18/2000 | US6051386 Introducing a stimulant to test cells of a pigment cell line expressing exogenous cell surface receptor to set an initial state of pigment disposition, contacting with test chemical; change in pigment disposition indicates an agonist |
| 04/18/2000 | US6051384 Method of detecting p53-specific antibodies |
| 04/18/2000 | US6051373 Methods for screening for inhibitors of the transcription-enhancing activity of the X protein of hepatitis B virus |
| 04/18/2000 | US6051239 Compositions and methods for systemic delivery of oral vaccines and therapeutic agents |
| 04/18/2000 | US6051237 Specific immunotherapy of cancer using a live recombinant bacterial vaccine vector |
| 04/18/2000 | US6051232 Comprising allogenic chimeric major histocompatibility complex class i milecule; to induce tolerance to donor grafts when administered to the recipient at time of transplantation |
| 04/18/2000 | US6051226 use of antibodies targeting the MN oncoprotein conjugated to an anticancer therapeutic agent such as drug or toxin for tissue targeted cancer therapy |
| 04/18/2000 | US6051222 Cancer diagnosis; genetic engineering |
| 04/18/2000 | US6051221 BRK protein tyrosine kinase and encoding nucleic acid |
| 04/18/2000 | US6051219 Method for reducing malodor with Bacillus subtilis Kubota |
| 04/18/2000 | US6051217 Administering to patient with hematopoietic or immunodeficiency |
| 04/18/2000 | US6051130 Bioreactor for remediation of pollutants with butane utilizing bacteria |
| 04/18/2000 | CA2192184C Extraction of heterologous insoluble proteins from bacteria |
| 04/13/2000 | WO2000020623A1 Resolution of trans-2 -(alkoxycarbonylethyl) -lactams useful in the synthesis of 1- (4-fluorophenyl) -3(r) -[3(s) -hydroxy-3 -(4-fluorophenyl) -propyl)] -4(s) -(4-hydroxyphenyl) -2-azetidinone |
| 04/13/2000 | WO2000020612A2 Therapeutically active proteins in plants |
| 04/13/2000 | WO2000020609A2 Protective recombinant haemophilus influenzae high molecular weight proteins |
| 04/13/2000 | WO2000020597A1 Novel strains of the bacillus subtilis group for food fermentation |
| 04/13/2000 | WO2000020596A1 Fungal transcriptional activator useful in methods for producing polypeptides |
| 04/13/2000 | WO2000020581A1 Mage-a3 peptides presented by hla class ii molecules |
| 04/13/2000 | WO2000020432A1 Antisense modulation of bcl-x expression |
| 04/13/2000 | WO2000020418A1 Xanthobaccin antibiotics |
| 04/13/2000 | WO2000019806A1 High temperature-tolerant plants |
| 04/13/2000 | WO2000003010A3 Protein secretion from bacteria having reduced expression of a product encoded by the dlt operon |
| 04/13/2000 | WO2000000634A3 METHODS OF INHIBITING $i(HELICOBACTER PYLORI) |
| 04/13/2000 | DE19846493A1 DNA sequence coding for products involved in the biosynthesis of polyketide or heteropolyketide compounds, especially epothilone |
| 04/13/2000 | CA2344973A1 Oxidoreductase molecules |
| 04/13/2000 | CA2344269A1 Therapeutically active proteins in plants |
| 04/13/2000 | CA2284850A1 Dna coding for protein which confers on bacterium escherichia coli resistance to l-homoserine, and method for producing l-amino acids |
| 04/12/2000 | EP0992588A1 DsbA/DsbB/DsbC/DsbD expression plasmid |
| 04/12/2000 | EP0992585A2 Human calcium channel compositions and methods |
| 04/12/2000 | EP0992584A2 Purified mammalian FLT3 ligands and agonists and antagonists thereof |
| 04/12/2000 | EP0992579A1 Stem cell factor |
| 04/12/2000 | EP0991775A1 Method to identify pesticidal microbes |
| 04/12/2000 | EP0991762A2 SURFACE PROTEIN (SPsA PROTEIN) OF STREPTOCOCCUS PNEUMONIAE, DELETED DERIVATIVES, EXPRESSION SYSTEM FOR SAID PROTEINS AND VACCINE SYSTEM WITH SAID PROTEINS |
| 04/12/2000 | EP0991754A2 Proteases from gram-positive organisms |
| 04/12/2000 | EP0676052B1 Detection of cystic fibrosis or a cftr gene mutation |
| 04/12/2000 | EP0452413B1 Generation and selection of novel dna-binding proteins and polypeptides |
| 04/12/2000 | EP0362218B2 IMPROVED METHOD FOR PRODUCING FACTOR VIII:c-TYPE PROTEINS |
| 04/12/2000 | CN1250480A Eukaryotic gene expression cassette and uses thereof |
| 04/12/2000 | CN1250475A Storage stable liquid formulation comprising a laccase |
| 04/12/2000 | CN1250102A Process for preparing fermented product and stress resistance microbe |
| 04/12/2000 | CN1250101A Application of new aminotransferase in amino transfer |
| 04/12/2000 | CN1250055A Production of recombination human lactoferritin |
| 04/11/2000 | US6048963 Polynucleotides and polypeptides associated with benign prostatic hypertrophy |
| 04/11/2000 | US6048839 Materials and methods for controlling insect pests with pesticidal proteins obtainable from Bacillus thuringiensis isolates PS158C2 and HD511 |
| 04/11/2000 | US6048730 Selectable marker for development of vectors and transformation systems in plants |
| 04/11/2000 | US6048716 Microorganism polypeptide; for infection prevention bactericides; wound healing agents |
| 04/11/2000 | US6048713 Pseudomonas fluorescens |
| 04/11/2000 | US6048711 Human G-protein coupled receptor polynucleotides |
| 04/11/2000 | US6048694 Screening for gram positive bacterial transformed with heterologus nucleic acids; constructing vector and inserting nucleic acids, destroying enzyme activity, transforming cell defective in sucrose metabolism, isolating transformant |
| 04/11/2000 | US6048526 Monoclonal antibodies reactive with defined regions of the T cell antigen receptor |
| 04/11/2000 | CA2220729C Method for refolding insoluble aggregates of hepatitis c virus protease |
| 04/11/2000 | CA2009579C Insulin analogs |
| 04/11/2000 | CA2002776C Detection of human papillomavirus dna and its expression in cervical smears |
| 04/09/2000 | CA2284117A1 Process for the preparation of pantothenic acid by amplification of nucleotide sequences which code for ketopantoate reductase |
| 04/06/2000 | WO2000018969A1 Methods to selectively inactivate viruses in biological compositions |
| 04/06/2000 | WO2000018961A2 Expression analysis of specific nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
| 04/06/2000 | WO2000018959A1 Trex, a novel gene of traf-interacting ext gene family and diagnostic and therapeutic uses thereof |
| 04/06/2000 | WO2000018940A1 Plants and plants cells encoding the wild type cop1 gene and the coil domain thereof |
| 04/06/2000 | WO2000018934A1 Peptidyl prolyl cis-trans isomerases |
| 04/06/2000 | WO2000018932A2 Receptor based antagonists and methods of making and using |
| 04/06/2000 | WO2000018919A1 Human kinesin-like motor protein |
| 04/06/2000 | WO2000018910A1 Moraxella catarrhalis protein, nucleic acid sequence and uses thereof |
| 04/06/2000 | WO2000018902A1 Method of screening for large offspring syndrome |
| 04/06/2000 | WO2000018899A2 Angiotensin converting enzyme homolog and its use |
| 04/06/2000 | WO2000018888A1 Immunomodulation by genetic modification of dendritic cells and b-cells |
| 04/06/2000 | WO2000018693A1 Microbiological method for eliminating a nitroaromatic compound |
| 04/06/2000 | WO2000018437A1 Tie2 antagonist antibodies |
| 04/06/2000 | WO1999065938A3 Fy7 polymerase |
| 04/06/2000 | WO1999061453A3 priA |
| 04/06/2000 | WO1999058683A3 BASB029 POLYNUCLEOTIDE(S) AND POLYPEPTIDES FROM $i(NEISSERIA MENINGITIDIS) |
| 04/06/2000 | WO1999057325A3 Enzymes mixture |
| 04/06/2000 | WO1999055730A3 Polyepitope carrier protein |
| 04/06/2000 | WO1999055132A3 Generation of packaging system for human recombinant adenoviral vectors |
| 04/06/2000 | CA2345230A1 Methods to selectively inactivate viruses in biological compositions |
| 04/06/2000 | CA2344658A1 Human kinesin-like motor protein |
| 04/06/2000 | CA2344622A1 Moraxella catarrhalis protein, nucleic acid sequence and uses thereof |
| 04/06/2000 | CA2344550A1 Expression analysis of specific nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
| 04/06/2000 | CA2344274A1 Angiotensin converting enzyme homolog and its use |
| 04/06/2000 | CA2344104A1 Method of screening for large offspring syndrome |
| 04/06/2000 | CA2343717A1 Better emergence characteristics and improved seedling growth under low-light environments |
| 04/06/2000 | CA2343656A1 Trex, a novel gene of traf-interacting ext gene family and diagnostic and therapeutic uses thereof |
| 04/06/2000 | CA2340789A1 Peptidyl prolyl cis-trans isomerases |
| 04/05/2000 | EP0990704A2 Non-reducing saccharide-forming enzyme, trehalose-releasing enzyme, and process for producing saccharides using the enzymes |
| 04/05/2000 | EP0990700A1 H. pylori fermentation process |
| 04/05/2000 | EP0990039A1 Increasing production of proteins in gram-positive microorganisms |
| 04/05/2000 | EP0990026A2 High-activity phytase granulate |
| 04/05/2000 | EP0990024A1 USE OF $i(LACTOBACILLUS) FOR REDUCTION OF THE FIBRINOGEN LEVEL IN BLOOD |
| 04/05/2000 | EP0990000A1 Connective tissue growth factor-3 |
| 04/05/2000 | EP0989995A2 Torsin, torsin genes, and methods of use |
| 04/05/2000 | EP0791046B1 Detergent compositions containing lipase and protease |
| 04/05/2000 | EP0777740B1 Genetic therapy of diseases of the central nervous system with a cell-specific active substance which is dependent on the cell cycle |
| 04/05/2000 | EP0777739B1 Genetic therapy of vascular diseases with a cell-specific active substance which is dependent on the cell cycle |
| 04/05/2000 | EP0758378B1 Thermostable xylanases |